The Survival of the Surviving Sepsis Campaign.
Sepsis
Surviving sepsis campaign
Treatment bundles
Journal
The Medical clinics of North America
ISSN: 1557-9859
Titre abrégé: Med Clin North Am
Pays: United States
ID NLM: 2985236R
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
entrez:
24
10
2022
pubmed:
25
10
2022
medline:
27
10
2022
Statut:
ppublish
Résumé
Even well-intentioned policies have great potential to cause harm. This statement is vividly illustrated by the influential, yet controversial, Surviving Sepsis Campaign guidelines and subsequent CMS benchmarks. Despite low-quality evidence, tendentious industry ties, and rebuke from the Infectious Disease Society of America (IDSA), these benchmarks continue to eschew therapy driven by clinician expertise and individual patient needs in favor of mandating an arbitrary, one-size-fits-all approach that suspends clinical judgment and promotes indiscriminate use of treatments that have the potential to cause great harm.
Identifiants
pubmed: 36280336
pii: S0025-7125(22)00099-2
doi: 10.1016/j.mcna.2022.08.006
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1109-1117Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.